Blinatumomab in de novo AYA ALL-Results of the Australasian Leukaemia and Lymphoma Group ALL09 "SUBLIME" study.
Saved in:
| Title: | Blinatumomab in de novo AYA ALL-Results of the Australasian Leukaemia and Lymphoma Group ALL09 "SUBLIME" study. |
|---|---|
| Authors: | Greenwood M; University of Sydney Sydney New South Wales Australia.; Department of Haematology Royal North Shore Hospital Sydney New South Wales Australia., Gangatharan S; Fiona Stanley Hospital Perth Western Australia Australia.; University of Western Australia Perth Western Australia Australia., Osborn M; Department of Haematology & Oncology Women's & Children's Hospital Adelaide South Australia Australia.; Youth Cancer Service Royal Adelaide Hospital Adelaide South Australia Australia.; Faculty of Health and Medical Sciences University of Adelaide Adelaide South Australia Australia., Ng AP; Department of Clinical Haematology The Royal Melbourne Hospital and Peter MacCallum Cancer Centre Melbourne Victoria Australia., Fleming S; The Alfred Hospital and Monash University Melbourne Victoria Australia., Fedele P; Monash Hospital Melbourne Victoria Australia., Trahair T; Sydney Children's Hospital Randwick New South Wales Australia.; Paediatrics and Child Health UNSW Medicine & Health University of New South Wales Sydney New South Wales Australia., Casey J; The Townsville Hospital Townsville Queensland Australia., Mapp S; Princess Alexandra Hospital Brisbane Queensland Australia., Cheung C; Prince of Wales Hospital Sydney New South Wales Australia., Armytage T; Gosford Hospital Gosford New South Wales Australia., Henderson M; Paediatrics and Child Health UNSW Medicine & Health University of New South Wales Sydney New South Wales Australia.; Children's Cancer Institute University of NSW Randwick New South Wales Australia., Sutton R; Paediatrics and Child Health UNSW Medicine & Health University of New South Wales Sydney New South Wales Australia.; Children's Cancer Institute University of NSW Randwick New South Wales Australia., Rehn J; Faculty of Health and Medical Sciences University of Adelaide Adelaide South Australia Australia.; Precision Cancer Medicine Theme South Australian Health and Medical Research Institute Adelaide South Australia Australia., Page E; Faculty of Health and Medical Sciences University of Adelaide Adelaide South Australia Australia.; Precision Cancer Medicine Theme South Australian Health and Medical Research Institute Adelaide South Australia Australia., Heatley S; Faculty of Health and Medical Sciences University of Adelaide Adelaide South Australia Australia.; Precision Cancer Medicine Theme South Australian Health and Medical Research Institute Adelaide South Australia Australia., Button P; McCloud Consulting Group Sydney New South Wales Australia., Rowley L; Australasian Leukaemia and Lymphoma Group Richmond Victoria Australia., Larsen SR; University of Sydney Sydney New South Wales Australia.; Institute of Haematology, Royal Prince Alfred Hospital Sydney New South Wales Australia., Presgrave P; Wollongong Hospital Wollongong New South Wales Australia., Kwan J; Department of Haematology and Blood Transplant and Cellular Therapies Program Westmead Hospital Sydney New South Wales Australia., Bennett S; The Canberra Hospital Canberra Australian Capital Territory Australia., Fong CY; Department of Haematology Austin Hospital Heidelberg Victoria Australia.; The University of Melbourne Melbourne Victoria Australia., Dalla Pozza L; The Children's Hospital at Westmead Sydney New South Wales Australia., Yeung D; Faculty of Health and Medical Sciences University of Adelaide Adelaide South Australia Australia.; Precision Cancer Medicine Theme South Australian Health and Medical Research Institute Adelaide South Australia Australia.; Department of Haematology Royal Adelaide Hospital Adelaide South Australia Australia., White D; Faculty of Health and Medical Sciences University of Adelaide Adelaide South Australia Australia.; Precision Cancer Medicine Theme South Australian Health and Medical Research Institute Adelaide South Australia Australia. |
| Corporate Authors: | Australasian Leukaemia and Lymphoma Group |
| Source: | HemaSphere [Hemasphere] 2026 Jan 23; Vol. 10 (1), pp. e70291. Date of Electronic Publication: 2026 Jan 23 (Print Publication: 2026). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Wiley Country of Publication: United States NLM ID: 101740619 Publication Model: eCollection Cited Medium: Internet ISSN: 2572-9241 (Electronic) Linking ISSN: 25729241 NLM ISO Abbreviation: Hemasphere Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2572-9241 |
|---|---|
| DOI: | 10.1002/hem3.70291 |
